TY - JOUR
T1 - Use of Y DNA probes to identify children at risk for dysgenetic gonadal tumors
AU - Tho, S. P.T.
AU - McDonough, P. G.
PY - 1987/1/1
Y1 - 1987/1/1
N2 - The occurrence of gonadal neoplasia in phenotypic females harboring dysgenetic gonads and Y chromosome material is well known. The precise determinants for oncogenesis in these subjects remain enigmatic. Assuming that the Y chromosome is the culprit, it is not possible at this time to identify the portion of the Y which predisposes to malignancy. Diligent search for Y chromosome material is mandatory in this group of patients with gonadal dysgenesis. However, the clinician is confronted with two dilemmas: 1) a minority population of cells with a Y chromosome in a putative 45X monosomic could remain undetectable despite careful and repeated cytogenetic examinations of various tissues, and 2) a minute chromosomal fragment suspected to be Y may remain unidentifiable with current cytogenetic techniques. Application of modern molecular biology to clinical medicine has opened new avenues to resolve these dilemmas. The purpose of this article is : 1) to reexamine the spectrum of Y aneuploidy leading to gonadal dysgenesis, tumor formation, and the inherent clinical dilemmas; 2) to review the molecular biology of the Y chromosome and the Y-specific DNA probes; and 3) to prove that these Y probes may serve as powerful tools for the resolution of the clinical dilemmas.
AB - The occurrence of gonadal neoplasia in phenotypic females harboring dysgenetic gonads and Y chromosome material is well known. The precise determinants for oncogenesis in these subjects remain enigmatic. Assuming that the Y chromosome is the culprit, it is not possible at this time to identify the portion of the Y which predisposes to malignancy. Diligent search for Y chromosome material is mandatory in this group of patients with gonadal dysgenesis. However, the clinician is confronted with two dilemmas: 1) a minority population of cells with a Y chromosome in a putative 45X monosomic could remain undetectable despite careful and repeated cytogenetic examinations of various tissues, and 2) a minute chromosomal fragment suspected to be Y may remain unidentifiable with current cytogenetic techniques. Application of modern molecular biology to clinical medicine has opened new avenues to resolve these dilemmas. The purpose of this article is : 1) to reexamine the spectrum of Y aneuploidy leading to gonadal dysgenesis, tumor formation, and the inherent clinical dilemmas; 2) to review the molecular biology of the Y chromosome and the Y-specific DNA probes; and 3) to prove that these Y probes may serve as powerful tools for the resolution of the clinical dilemmas.
UR - http://www.scopus.com/inward/record.url?scp=0023220684&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0023220684&partnerID=8YFLogxK
U2 - 10.1097/00003081-198709000-00023
DO - 10.1097/00003081-198709000-00023
M3 - Review article
C2 - 3308256
AN - SCOPUS:0023220684
SN - 0009-9201
VL - 30
SP - 671
EP - 681
JO - Clinical Obstetrics and Gynecology
JF - Clinical Obstetrics and Gynecology
IS - 3
ER -